Effect of Korean Red Ginseng Extract on Cell Death Responses in Peroxynitrite-Treated Keratinocytes

Effect of Korean Red Ginseng Extract on Cell Death Responses in Peroxynitrite-Treated Keratinocytes
复制标题

DOI:
10.5142/jgr.2010.34.3.205
复制
发表时间:
2010-09-01
影响因子:
6.3
通讯作者:
Park, Jong Kun
Park, Jong Kun
中科院分区:
医学2区
文献类型:
--
作者:
Do Kim, Hyoung;Ha, Se Eun;Park, Jong Kun

文献摘要

被引文献

相似文献

韩国红参(KRG)已在世界范围内被用作治疗各种疾病的传统药物,包括癌症。在这项研究中,我们确定了KRG对HaCaT细胞对过氧亚硝酸盐(ONOO-)的反应的影响。在与对照培养基一起孵育12小时之前用ONOO-(2 mM)处理的细胞显示出降低的活力,如使用3[4,5-二甲基噻唑-2-基]-2,5-二苯基四唑溴化物测定所测定的(活力约为未处理的对照细胞的活力的48%)。当KRG被添加到培养后的培养基中时,ONOO-对细胞活力的负面影响显著降低。逆转录聚合酶链反应分析表明,KRG单独没有显着改变p53或“生长停滞和DNA损伤”(GADD)45 mRNA水平。然而,在ONOO处理的细胞中,在孵育后培养基中加入KRG显著且剂量依赖性地降低了p53和GADD 45 mRNA的水平。Western印迹分析显示,与对照培养基孵育的细胞相比,与KRG孵育降低了ONOO处理的细胞中p53和GADD 45蛋白水平。总的来说,这些结果表明,韩国红参提取物保护细胞对ONOO-诱导的遗传毒性,通过调节p53信号传导中间体的表达,增加细胞活力。
Korean red ginseng (KRG) has been used worldwide as a traditional medicine for the treatment of various diseases, including cancer. In this study, we determined the effect of KRG on the responses of HaCaT cells to peroxynitrite (ONOO-). Cells treated with ONOO- (2 mM) prior to incubation with control medium for 12 hours displayed reduced viability, as determined using the 3[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay (viability about 48% of that of non-treated control cells). When KRG was added to the post-incubation medium, the negative effects of ONOO- on cell viability were significantly reduced. Reverse transcription-polymerase chain reaction analysis indicated that KRG alone did not significantly alter p53 or "growth arrest and DNA damage" (GADD)45 mRNA levels. However, the addition of KRG to the post-incubation medium significantly and dose-dependently reduced levels of p53 and GADD45 mRNA in ONOO--treated cells. Western blot analyses revealed that incubation with KRG decreased p53 and GADD45 protein levels in ONOO--treated cells, relative to those in cells incubated with control medium. Collectively, these results suggest that Korean red ginseng extract protects cells against ONOO--induced genotoxicity by increasing cell viability through modulating the expression of p53 signaling intermediates.